Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS)
Clinical trial NCT01542684 · TERMINATED
Trial details
- NCT number
- NCT01542684
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2013-04-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.